C12N 5/0676
Pancreatic cells
Official title: {Pancreatic cells}
C12N5/0676 (Pancreatic cells) appears on 817 US grants and 1,422 published applications in this corpus.
Search patents in C12N- Granted patents
- 817
- Published applications
- 1,422
- Assignees
- 528
- Inventors
- 1,960
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 5 | 0 |
| 1996 | 15 | 0 |
| 1997 | 18 | 0 |
| 1998 | 29 | 0 |
| 1999 | 26 | 0 |
| 2000 | 12 | 0 |
| 2001 | 9 | 6 |
| 2002 | 13 | 27 |
| 2003 | 10 | 47 |
| 2004 | 7 | 44 |
| 2005 | 13 | 40 |
| 2006 | 13 | 29 |
| 2007 | 7 | 39 |
| 2008 | 14 | 37 |
| 2009 | 13 | 37 |
| 2010 | 8 | 44 |
| 2011 | 8 | 43 |
| 2012 | 17 | 55 |
| 2013 | 17 | 59 |
| 2014 | 33 | 59 |
| 2015 | 38 | 60 |
| 2016 | 39 | 73 |
| 2017 | 42 | 81 |
| 2018 | 49 | 78 |
| 2019 | 57 | 88 |
| 2020 | 47 | 78 |
| 2021 | 52 | 80 |
| 2022 | 42 | 78 |
| 2023 | 36 | 67 |
| 2024 | 37 | 75 |
| 2025 | 47 | 48 |
| 2026 | 32 | 50 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Neo-Islets comprising stem and islet cells and treatment of diabetes mellitus therewith6 Oct 2026US 12,753,392 B2SymbioCellTech, LLC
- Methods for reducing elevated glucose levels11 Aug 2026US 12,703,856 B2SDF BioPharma Inc.
- Microgel particles for use in 3D printing and 3D cell growth medium and related compositions, systems, and methods28 Jul 2026US 12,692,474 B2University of Florida Research Foundation, Inc.
- Generation of pancreatic endoderm from stem cell derived definitive endoderm21 Jul 2026US 12,686,855 B2Aspect Biosystems Ltd.
- Proliferative liver organoid, metabolically activated liver organoid, and use thereof14 Jul 2026US 12,680,080 B2Jsr Corporation
- Compositions and methods for propogating insulin and glucagon secreting cells from type 1 diabetic pancreatic tissue and therapeutic uses thereof8 Oct 2026US 2026/0308529 A1Imagine Pharma LLC
- Compositions and methods for propagating insulin- producing islet cells and therapeutic uses thereof cross reference to related applications8 Oct 2026US 2026/0308530 A1Imagine Pharma LLC
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- Ribosomal Remodeling in Diabetes1 Oct 2026US 2026/0295074 A1Joslin Diabetes Center, Inc.
- Cells, islets, and organoids that evade immune detection and autoimmunity, methods of production and use thereof1 Oct 2026US 2026/0297530 A1The Salk Institute for Biological Studies
Most cited
By later US patents
- Renewable neural implant device and method1,456US 5,554,148 ABrown University Research Foundation · 1996
- Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers896US 5,410,016 ABoard of Regents, The University of Texas System · 1995
- Encapsulation of biological material667US 4,352,883 ADamon Corporation · 1982
- Gels for encapsulation of biological materials587US 5,858,746 ABoard of Regents, The University of Texas System · 1999
- Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products448US 6,083,523 ABrown University · 2000